rs374172497
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-A
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-AT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
- chr2-181677112-ATTTTTTTTTTTTTTTTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_002500.5(NEUROD1):c.*654_*677delAAAAAAAAAAAAAAAAAAAAAAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002500.5 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- CERKL-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- retinitis pigmentosa 26Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROD1 | NM_002500.5 | c.*654_*677delAAAAAAAAAAAAAAAAAAAAAAAA | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000295108.4 | NP_002491.3 | ||
NEUROD1 | NR_146175.2 | n.88+3294_88+3317delAAAAAAAAAAAAAAAAAAAAAAAA | intron_variant | Intron 1 of 1 | ||||
NEUROD1 | NR_146176.2 | n.88+3294_88+3317delAAAAAAAAAAAAAAAAAAAAAAAA | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000203 AC: 1AN: 49326Hom.: 0 Cov.: 0 show subpopulations
GnomAD4 genome AF: 0.0000203 AC: 1AN: 49326Hom.: 0 Cov.: 0 AF XY: 0.0000464 AC XY: 1AN XY: 21530 show subpopulations
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at